Accord Takes A Trio Of Awards
As A Host Of Leading Off-Patent Industry Firms Also Rewarded
Accord Healthcare took home a trio of prizes at the Global Generics & Biosimilars Awards 2020, with other winners including Alvogen, Aurobindo, Dr Reddy’s, Eurofarma, Insud Pharma, Macleods, Pinsent Masons, Samsung Bioepis, Sandoz, Stada and Zentiva.
You may also be interested in...
Generics firms are increasingly adopting a more integrated approach to corporate social responsibility activities, including product donations, as part of their strategy as they work alongside organizations such as International Health Partners, the charity’s CEO Adele Paterson tells Generics Bulletin.
Sandoz is benefiting from its focus on a “pure play” generics and biosimilars model that is unique among its peers, CEO Richard Saynor tells Generics Bulletin in an exclusive interview.
Accord expects to maintain its historically high growth rates through a “holistic” approach to medicines that covers generics and biosimilars alongside more innovative products, with recent marketing alliances in Europe playing into the firm’s ambitions in the CNS area.